"The Virtua Samson Cancer Center in Moorestown is part of the Penn Medicine | Virtua Cancer program. It provides preventative, diagnostic and treatment services for patients with many types of cancer. The integrated team of oncology specialists at the Samson Cancer Center are dedicated to providing individualized, state-of-the-art treatment for a multitude of cancer diagnoses."

During the past decade, Virtua Samson Cancer Center conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 4 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virtua Samson Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 11 trials, followed by "SWOG Cancer Research Network" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "NRG Oncology" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virtua Samson Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Virtua Samson Cancer Center" are "Stage IV Lung Cancer AJCC v8" (8 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials), "Stage IVB Lung Cancer AJCC v8" (6 trials), "Recurrent Lung Non-Small Cell Carcinoma" (5 trials) and "Stage IIIB Lung Cancer AJCC v8" (4 trials). Many other conditions were trialed in "Virtua Samson Cancer Center" in a lesser frequency.

Most popular intervention types in "Virtua Samson Cancer Center" are "Drug" (23 trials), "Other" (14 trials), "Biological" (11 trials), "Procedure" (6 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (8 trials), "Carboplatin" (7 trials), "Quality-of-Life Assessment" (7 trials), "Cisplatin" (6 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Virtua Samson Cancer Center" are 22 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Virtua Samson Cancer Center". undefined are not yet recruiting, 13 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Virtua Samson Cancer Center, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Virtua Samson Cancer Center, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".